focus -WSS

focus

author：leisure time 2025-10-01 00:58:11 - browse：36277

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Scientists grapple with ethics of stem cell research

leisure time

WSS

Fight over Supreme Court dialysis ruling puts kidney patients at risk

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Dementia risk linked to living in disadvantaged areas: Study

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

ASCO Daily Recap: CAR

Hormonal contraceptives don’t actually treat endometriosis

explore

focus

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Congress needs to close a vaccine

Anesthesiologist group: stop taking Ozempic before surgery

STAT wants to know your pick for a great summer read or listen

Cancer drug shortages should be causing more outrage

A new initiative will help leaders fight the next pandemic

Bright Health sells Medicare Advantage business to Molina

Sutter Health’s antitrust win overturned by appeals court

What does generative AI mean for health care? We asked experts

How a Boston hospital is priming medical residents to use GPT

focus

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Caribou posts encouraging results on off

US jobless claims fall again as labor market continues to flash strength

The most pressing bird flu mysteries scientists want answered

FTC loses bid to block Novant's North Carolina hospital merger

An outdated Medicare rule harms dementia patients with anxiety

entertainment

entertainment

leisure time

hotspot